Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Production |
| Species: | Llama |
| Stage: | Assays Completed |
| Study Start Date: | 2010-10-27 |
| Study Made Public: | 2011-11-15 |
Title
Weiss Forsman Llama study
Description
CAVD 329 is a continuation of CAVD 289. Both studies isolated llama VHH antibody fragments from llamas immunized with HIV-1 ENV proteins. The VHH were selected for targeting the CD4 binding site.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.